Collaborative research:

Chemical biology networks

In May 2011 BBSRC, EPSRC, and MRC jointly invested £1.2M in seven networks to improve collaboration between academia and industry at the chemical biology interface.

In addition to the Research Councils' investment, over 20 user organisations, including AstraZeneca, Bayer, Cancer Research UK, GlaxoSmithKline, the NHS, Pfizer, Syngenta and UCB are investing significant resource in seven separate networks.

The networks will collaborate on a range of activities to enable knowledge-sharing and innovative discipline-hopping between academia and users across the breadth of chemical biology research and development.

Chemical biology is the use of chemistry and chemical tools to understand and solve biological problems. It is an area of great economic value as it is an essential component of innovative research in areas such as:

The networks

The academic collaborators leading the seven networks are: